Kara E. McCloskey
The marriage of science, technology and medicine holds endless promise for humankind. Breakthroughs in the study and mapping of the human genome have spawned entirely new fields of research aimed at regenerative medicine - the repair or replacement of injured or destroyed body tissue with biologically engineered substitutes.
This, in turn, has triggered the rapid emergence of new industries and collaborations dedicated to bringing tissue-engineered products to the medical marketplace. McCloskey is a chemical engineer who applies standard engineering principles, such as analysis and design, to the field of stem cells and tissue engineering. She can comment broadly on the science and technology of biomedical engineering and the process by which new tissue products may be developed and tested. She is also capable of framing the issues around stem-cell technology and cloning, which have emerged as lightning-rod issues throughout the world.
McCloskey earned both her B.S. and M.S. in chemical engineering from Ohio State University. She holds a Ph. D. jointly from Ohio State and the Cleveland Clinic Foundation. She has co-authored numerous articles on stem cells and cell properties.